Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
Merlintrader Trading Pub
Biotech catalyst, news and analysis PDUFA tracker
AI transparency: articles and reports are produced with the help of artificial intelligence and checked through a process that does not constitute specialist validation. They may contain errors: verify relevant information with independent sources. Read the full disclaimer.
Oct 16, 2026, 4:55 PM ET
NioCorp reported net income attributable to NioCorp of $3.7 million, or $0.03 per share (basic), for the three-month period ended September 30, 2026, versus a net loss of $42.7 million in the prior-year period.
Nasdaq: $NBCritical minerals · Elk Creek
NB Stock Hub: NioCorp News, Elk Creek Financing and Traxys Sales Terms
NioCorp is advancing Elk Creek with an updated study, portal construction and a new Traxys agreement. Preliminary September cash was $405.1 million, while projected upfront capital is approximately $1.85 billion. EXIM retains an approximate 65% debt-financing target, subject to its continuing review. The company intends to file its September-quarter statements on or before November 16.
Full research report · PDF
NioCorp Developments Ltd. research · November 1, 2026
19 pages covering the business, financial position, catalysts, risks, scenarios and sources. A dated snapshot for personal use; redistribution prohibited.
Next catalyst
2026-11-16 · September-quarter Form 10-Q filing
company intends to file on or before this date; preliminary results remain subject to change Announcement and terms
NB stock at a glance
Indicative equity value
487.1
USD million · 2026-10-30 · Calculated $3.34 × 145,849,630 shares outstanding on September 25; dated basic share count, not a fully diluted valuation.
SourcePreliminary cash balance
405.1
USD million · 2026-09-30 · Preliminary unaudited company update; subject to change in the quarterly statements.
SourcePreliminary quarterly operating cash flow
-6.1
USD million · 2026-07-01/2026-09-30 · Preliminary unaudited operating cash outflow; subject to change.
SourcePreliminary quarterly investing cash flow
-5.9
USD million · 2026-07-01/2026-09-30 · Preliminary unaudited investing outflow, principally mine-portal work; subject to change.
SourceProjected upfront project capital
1.85
USD billion · 2026-06-30 · 2026 study estimate, including $233 million contingency; not spending already completed.
SourceEXIM indicated debt-financing target
65.00
percent of upfront capital, approximate · 2026-10-14 · Target retained in the support letter; review continues and financing is not finally authorized or committed.
SourceWhere NioCorp Developments Ltd. stands now
Elk Creek has a more defined technical and commercial framework, but the full construction package remains to be financed and executed. The 2026 study is classified as feasibility under Canadian NI 43-101 and pre-feasibility under U.S. S-K 1300, with additional surface-plant engineering and procurement identified.
The October Traxys agreement separates take-or-pay ferroniobium volume from exclusive marketing rights, without a purchase obligation, for other products. Preliminary quarterly net income largely reflected noncash financial-instrument gains; operating cash flow remained negative. These distinctions matter when connecting the study to cash available for shareholders.
The main risk is that construction funding, costs, schedule or specialty-product realizations fall short of the study assumptions. Current cash supports development, while a larger financing package, customer acceptance and the economics retained after funding and other claims will determine the common-share outcome.
The constructive case
Engineering, procurement and financing establish an executable construction plan, while qualified customers support the product basket and funding leaves a worthwhile residual equity claim.
The cautious case
Capital or schedule requirements rise, specialty-product realizations disappoint or financing terms transfer much of the projected value away from current common holders.
Latest NioCorp Developments Ltd. news
Oct 16, 2026
Preliminary September-quarter financial update
Cash was preliminarily $405.1 million. Net income of $3.7 million largely reflected noncash instrument gains; operating cash outflow was $6.1 million. Quarterly filing intended on or before November 16.
Oct 15, 2026
EXIM support reiterated with financing review ongoing
The support letter retained an approximate 65% upfront-capital debt target, subject to due diligence and subsequent internal review. It was not final loan approval.
Oct 13, 2026
New Traxys commercial agreement signed
Specified ferroniobium volume has take-or-pay terms. Other products are covered by an exclusive marketing right without a purchase obligation, with commissions and costs affecting realization.
Sep 25, 2026
Annual report and S-K 1300 technical report filed
The annual report gives the updated project economics, capital estimates and ownership structure. The study is a pre-feasibility study under U.S. S-K 1300, alongside its Canadian feasibility classification.
Aug 10, 2026
Updated Elk Creek technical and economic study announced
The modeled project has a forty-year mine life and eight planned product categories. Pre-tax NPV at 8% is approximately $4.1 billion, subject to the study assumptions and funding.
Aug 4, 2026
Non-binding Lockheed Martin memorandum
The memorandum concerns possible purchases of up to fifteen tonnes a year of scandium oxide or corresponding alloy forms over ten years. It is not a definitive purchase commitment.
NB stock catalysts
- 2026-11-16 · September-quarter Form 10-Q filingcompany intends to file on or before this date; preliminary results remain subject to change
- No firm approval date announced · EXIM due diligence and further internal reviewongoing review; no final loan authorization or financial close established
- Development work before greater cost definition and full execution · Additional surface-plant engineering and procurementrequired work identified in the U.S. technical-study classification
- 2027-12-31 · Traxys financing-related termination conditioncontractual condition, not a company promise of funding; specified extension may apply
- Sixty months after October 13, 2026 execution, subject to stated qualifications · Commercial-production timing condition under Traxys agreementcontractual termination provision with notice and force-majeure terms; not a forecast production date
What the October Traxys terms establish
| Product group | Commercial terms in the filing |
|---|---|
| Ferroniobium | Take-or-pay purchase of 50% of annual output or, at Traxys’ election, 3,700 metric tonnes a year, subject to exclusions. |
| Other products | Exclusive right, without an obligation, to market and sell; commissions and specified costs reduce realization. |
| Duration and development | Fifteen years from the defined commercial-production date, with financing and production timing conditions. |
Financial resources and construction are different scales
| Measure | Amount and status |
|---|---|
| September cash | $405.1 million; preliminary unaudited, as of September 30, 2026. |
| Quarterly operating cash flow | Negative $6.1 million; preliminary July–September 2026. |
| Projected upfront capital | $1.849 billion, including $233 million contingency, in the 2026 study. |
| EXIM debt target | Approximately 65% of upfront capital, with review continuing and no final commitment established. |
Preliminary financial update · Study and capital assumptions · EXIM status
Merlintrader Health Score · $NB
2.80out of 5
Assessed November 1, 2026. An editorial assessment of financial and operating resilience over twelve to eighteen months; no price target or recommendation is implied.
Red flags
- EXIM support and an indicated financing target are not final loan authorization or disbursement.
- Traxys has no obligation to purchase the products covered only by its exclusive marketing right.
- Scandium and rare earths contribute materially to projected lifetime revenue.
- The preliminary September financial figures remain unaudited and subject to change.
- Fiscal 2026 fundraising increased cash and the common-share base substantially.
- Surface-plant engineering and procurement remain important to cost definition and the U.S. study classification.
- Subsidiary interests, warrants, exchanges and future financing affect the value attributable to current common shares.
NB Stock FAQ: NioCorp Developments Ltd. Questions Answered
Has EXIM approved the loan?
The October letter retains a financing target while due diligence and further internal review continue. It does not establish final authorization, financial close or disbursement.
Must Traxys buy every planned product?
Specified ferroniobium volume has take-or-pay terms. Other products have an exclusive marketing route without a Traxys purchase obligation.
Why did the preliminary quarter show net income?
The company identified approximately $8.5 million of noncash gains on liability-classified warrants and earnout shares. Operating cash flow remained negative.
What is the study classification?
A feasibility study under Canadian NI 43-101 and a pre-feasibility study under U.S. S-K 1300; additional surface-plant work is required for the U.S. feasibility classification.
Is Lockheed Martin a guaranteed customer?
The August memorandum is non-binding. Definitive terms, qualification and actual purchases remain separate steps.
Primary sources and market references
Disclaimer. Published by Merlintrader for educational and informational purposes only. This content does not constitute investment advice or a recommendation to buy, sell or hold securities. Verify figures against the dated primary disclosures. Investors can lose part or all of their capital.
Mineral-development companies face geological, processing, construction, permitting, environmental, customer, commodity-price, financing and dilution risks. Technical-study economics depend on assumptions and do not establish equity value. Government support can remain conditional, marketing agreements may lack purchase obligations, and project interests and future capital can change the value retained by common shareholders.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz, which may generate a commission at no cost to the reader. Full legal information: disclaimer and terms of use and privacy.
